Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders

Neurotoxicology and Teratology

Volumn 36, Issue , 2013, Pages 3-16

  Stamou, Marianna ^a   Streifel, Karin M ^a   Goines, Paula E ^a   Lein, Pamela J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism Spectrum Disorders; Gene environment interactions; Neuronal connectivity; Organophosphorus pesticides; Polyaromatic hydrocarbons; Polychlorinated biphenyls

Indexed keywords

CALCIUM ION; CONTACTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUREXIN; NEUROLIGIN; ORGANOPHOSPHATE PESTICIDE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON;

AUTISM; CALCIUM CELL LEVEL; CALCIUM SIGNALING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL NETWORK; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; SYNAPTIC MEMBRANE;

ANIMALS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURONS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84875647486     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.12.001     Document Type: Review

References (271)

1. Aamodt S.M., Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv Neurol 1999, 79:133-144.
2. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355.
3. Abuhatzira L., Makedonski K., Kaufman Y., Razin A., Shemer R. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics 2007, 2:214-222.
4. Adgate J.L., Barr D.B., Clayton C.A., Eberly L.E., Freeman N.C., Lioy P.J., et al. Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ Health Perspect 2001, 109:583-590.
5. Alarcon M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008, 82:150-159.
6. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci 2008, 31:137-145.
7. Amir R.E., Van Den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
8. Androutsopoulos V.P., Kanavouras K., Tsatsakis A.M. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol 2011, 256:418-424.
9. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008, 82:160-164.
10. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008, 82:165-173.
11. Baron-Cohen S., Lombardo M.V., Auyeung B., Ashwin E., Chakrabarti B., Knickmeyer R. Why are autism spectrum conditions more prevalent in males?. PLoS Biol 2011, 9:e1001081.
12. Barr D.B., Bravo R., Weerasekera G., Caltabiano L.M., Whitehead R.D., Olsson A.O., et al. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 2004, 112:186-200.
13. Barr D.B., Allen R., Olsson A.O., Bravo R., Caltabiano L.M., Montesano A., et al. Concentrations of selective metabolites of organophosphorus pesticides in the United States population. Environ Res 2005, 99:314-326.
14. Barrientos G.C., Feng W., Truong K., Matthaei K.I., Yang T., Allen P.D., et al. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle. J Biol Chem 2012, 287:2863-2876.
15. Belmonte M.K., Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 2006, 9:1221-1225.
16. Betancourt A.M., Burgess S.C., Carr R.L. Effect of developmental exposure to chlorpyrifos on the expression of neurotrophin growth factors and cell-specific markers in neonatal rat brain. Toxicol Sci 2006, 92:500-506.
17. Betancourt A.M., Filipov N.M., Carr R.L. Alteration of neurotrophins in the hippocampus and cerebral cortex of young rats exposed to chlorpyrifos and methyl parathion. Toxicol Sci 2007, 100:445-455.
18. Bonora E., Beyer K.S., Lamb J.A., Parr J.R., Klauck S.M., Benner A., et al. Analysis of reelin as a candidate gene for autism. Mol Psychiatry 2003, 8:885-892.
19. Borodinsky L.N., Root C.M., Cronin J.A., Sann S.B., Gu X., Spitzer N.C. Activity-dependent homeostatic specification of transmitter expression in embryonic neurons. Nature 2004, 429:523-530.
20. Bouchard M.F., Chevrier J., Harley K.G., Kogut K., Vedar M., Calderon N., et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect 2011, 119:1189-1195.
21. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol 2009, 19:231-234.
22. Brown L.A., Khousbouei H., Goodwin J.S., Irvin-Wilson C.V., Ramesh A., Sheng L., et al. Down-regulation of early ionotrophic glutamate receptor subunit developmental expression as a mechanism for observed plasticity deficits following gestational exposure to benzo(a)pyrene. Neurotoxicology 2007, 28:965-978.
23. Cao Z., Hulsizer S., Tassone F., Tang H.T., Hagerman R.J., Rogawski M.A., et al. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet 2012, 21:2923-2935.
24. 2+ dynamics in cultured hippocampal neurons: mitigation by NMDA blockade and GABAA receptor positive modulation. Toxicol Sci 2012, 130(2):362-372. (Dec).
25. Carpenter D.O. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 2006, 21:1-23.
26. CDC Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 Sites, United States 2008, J. Baio (Ed.).
27. Chang Q., Khare G., Dani V., Nelson S., Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49:341-348.
28. Chapleau C.A., Larimore J.L., Theibert A., Pozzo-Miller L. Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodevelopmental Disord 2009, 1:185-196.
29. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
30. Chen Y., Tassone F., Berman R.F., Hagerman P.J., Hagerman R.J., Willemsen R., et al. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 2010, 19:196-208.
31. Cherednichenko G, Zhang R, Bannister RA, Timofeyev V, Li N, Fritsch EB, et al. Triclosan impairs excitation-contraction coupling and Ca2+ dynamics in striated muscle. Proc Natl Acad Sci U S A in press. http://dx.doi.org/10.1073/pnas.1211314109.
32. Chess S., Fernandez P., Korn S. Behavioral consequences of congenital rubella. J Pediatr 1978, 93:699-703.
33. Chih B., Afridi S.K., Clark L., Scheiffele P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 2004, 13:1471-1477.
34. Choi Y.B., Li H.L., Kassabov S.R., Jin I., Puthanveettil S.V., Karl K.A., et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in Aplysia. Neuron 2011, 70:468-481.
35. Chonchaiya W., Au J., Schneider A., Hessl D., Harris S.W., Laird M., et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012, 131:581-589.
36. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
37. Cline H.T. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 2001, 11:118-126.
38. Cole T.B., Beyer R.P., Bammler T.K., Park S.S., Farin F.M., Costa L.G., et al. Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression. Toxicol Sci 2011, 123:155-169.
39. Comoletti D., De Jaco A., Jennings L.L., Flynn R.E., Gaietta G., Tsigelny I., et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 2004, 24:4889-4893.
40. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 2007, 17:43-52.
41. Curl C.L., Fenske R.A., Elgethun K. Organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets. Environ Health Perspect 2003, 111:377-382.
42. da Silva S., Wang F. Retrograde neural circuit specification by target-derived neurotrophins and growth factors. Curr Opin Neurobiol 2011, 21:61-67.
43. Dahlhaus R., Hines R.M., Eadie B.D., Kannangara T.S., Hines D.J., Brown C.E., et al. Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus. Hippocampus 2010, 20:305-322.
44. 2+ homeostasis converts pro-Met into non-canonical tyrosine kinase p190MetNC in response to endoplasmic reticulum stress in MHCC97 cells. J Biol Chem 2012, 287:14586-14597.
45. Dam K., Seidler F.J., Slotkin T.A. Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Brain Res Dev Brain Res 1999, 118:129-133.
46. D'Amelio M., Ricci I., Sacco R., Liu X., D'Agruma L., Muscarella L.A., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 2005, 10:1006-1016.
47. Davis D.L., Ahmed A.K. Exposures from indoor spraying of chlorpyrifos pose greater health risks to children than currently estimated. Environ Health Perspect 1998, 106:299-301.
48. De Ferrari G.V., Moon R.T. The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 2006, 25:7545-7553.
49. de Vrij F.M., Levenga J., van der Linde H.C., Koekkoek S.K., De Zeeuw C.I., Nelson D.L., et al. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 2008, 31:127-132.
50. Dean C., Dresbach T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 2006, 29:21-29.
51. DeCaprio A.P., Johnson G.W., Tarbell A.M., Carpenter D.O., Chiarenzelli J.R., Morse G.S., et al. Polychlorinated biphenyl (PCB) exposure assessment by multivariate statistical analysis of serum congener profiles in an adult Native American population. Environ Res 2005, 98:284-302.
52. Dennis E.L., Jahanshad N., Rudie J.D., Brown J.A., Johnson K., McMahon K.L., et al. Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2. Brain Connectivity 2011, 1:447-459.
53. DeSoto M.C. Ockham's Razor and autism: the case for developmental neurotoxins contributing to a disease of neurodevelopment. Neurotoxicology 2009, 30:331-337.
54. DeVito T.J., Drost D.J., Neufeld R.W., Rajakumar N., Pavlosky W., Williamson P., et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2007, 61:465-473.
55. Devlin B., Bennett P., Dawson G., Figlewicz D.A., Grigorenko E.L., McMahon W., et al. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Med Genet B Neuropsychiatr Genet 2004, 126B:46-50.
56. Dolen G., Osterweil E., Rao B.S., Smith G.B., Auerbach B.D., Chattarji S., et al. Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
57. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27.
58. Edwards S.C., Jedrychowski W., Butscher M., Camann D., Kieltyka A., Mroz E., et al. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and children's intelligence at 5years of age in a prospective cohort study in Poland. Environ Health Perspect 2010, 118:1326-1331.
59. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008, 14:843-848.
60. El-Fishawy P., State M.W. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 2010, 33:83-105.
61. Engel S.M., Berkowitz G.S., Barr D.B., Teitelbaum S.L., Siskind J., Meisel S.J., et al. Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am J Epidemiol 2007, 165:1397-1404.
62. Engel S.M., Wetmur J., Chen J., Zhu C., Barr D.B., Canfield R.L., et al. Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect 2011, 119:1182-1188.
63. Eskenazi B., Bradman A., Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect 1999, 107(Suppl. 3):409-419.
64. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 2007, 115:792-798.
65. Ey E., Leblond C.S., Bourgeron T. Behavioral profiles of mouse models for autism spectrum disorders. Autism Res 2011, 4:5-16.
66. Forster E., Bock H.H., Herz J., Chai X., Frotscher M., Zhao S. Emerging topics in Reelin function. Eur J Neurosci 2010, 31:1511-1518.
67. Frotscher M., Drakew A., Heimrich B. Role of afferent innervation and neuronal activity in dendritic development and spine maturation of fascia dentata granule cells. Cereb Cortex 2000, 10:946-951.
68. Gaita L., Manzi B., Sacco R., Lintas C., Altieri L., Lombardi F., et al. Decreased serum arylesterase activity in autism spectrum disorders. Psychiatry Res 2010, 180:105-113.
69. Gandino L., Di Renzo M.F., Giordano S., Bussolino F., Comoglio P.M. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. Oncogene 1990, 5:721-725.
70. Gandino L., Munaron L., Naldini L., Ferracini R., Magni M., Comoglio P.M. Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene. J Biol Chem 1991, 266:16098-16104.
71. Geschwind D.H. Advances in autism. Annu Rev Med 2009, 60:367-380.
72. Geschwind D.H. Genetics of autism spectrum disorders. Trends Cogn Sci 2011, 15:409-416.
73. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007, 17:103-111.
74. Gong R., Park C.S., Abbassi N.R., Tang S.J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 2006, 281:18802-18815.
75. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
76. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
77. Grether J.K., Rosen N.J., Smith K.S., Croen L.A. Investigation of shifts in autism reporting in the California Department of Developmental Services. J Autism Dev Disord 2009, 39:1412-1419.
78. Grifman M., Galyam N., Seidman S., Soreq H. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc Natl Acad Sci U S A 1998, 95:13935-13940.
79. Gronert G.A., Pessah I.N., Muldoon S.M., Tautz T.J. Malignant hyperthermia. Anesthesia 2004, Churchill Livingstone, Philadelphia, PA. R. Miller (Ed.).
80. Gutierrez R.C., Hung J., Zhang Y., Kertesz A.C., Espina F.J., Colicos M.A. Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience 2009, 162:208-221.
81. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
82. Hagerman R., Au J., Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. J Neurodev Disord 2011, 3:211-224.
83. Halladay A.K., Amaral D., Aschner M., Bolivar V.J., Bowman A., DiCicco-Bloom E., et al. Animal models of autism spectrum disorders: information for neurotoxicologists. Neurotoxicology 2009, 30:811-821.
84. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
85. Hany J., Lilienthal H., Sarasin A., Roth-Harer A., Fastabend A., Dunemann L., et al. Developmental exposure of rats to a reconstituted PCB mixture or Aroclor 1254: effects on organ weights, aromatase activity, sex hormone levels, and sweet preference behavior. Toxicol Appl Pharmacol 1999, 158:231-243.
86. Harrill J.A., Robinette B.L., Mundy W.R. Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol In Vitro 2011, 25:368-387.
87. He Y., Xun G., Xia K., Hu Z., Lv L., Deng Z., et al. No significant association between RELN polymorphism and autism in case-control and family-based association study in Chinese Han population. Psychiatry Res 2011, 187:462-464.
88. Herbert M.R. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol 2010, 23:103-110.
89. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
90. Higgins D., Burack M., Lein P., Banker G. Mechanisms of neuronal polarity. Curr Opin Neurobiol 1997, 7:599-604.
91. Hood D.B., Nayyar T., Ramesh A., Greenwood M., Inyang F. Modulation in the developmental expression profile of Sp1 subsequent to transplacental exposure of fetal rats to desorbed benzo[a]pyrene following maternal inhalation. Inhal Toxicol 2000, 12:511-535.
92. Hornbuckle K.C., Carlson D.L., Swackhamer D.L., Baker J.E., Eisenreich S.J. Polychlorinated biphenyls in the Great Lakes. The handbook of environmental chemistry: persistent organic pollutants in the Great Lakes 2006, 13-70. Springer-Verlag, Berlin. R.A. Hites (Ed.).
93. Howard A.S., Bucelli R., Jett D.A., Bruun D., Yang D., Lein P.J. Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol Appl Pharmacol 2005, 207:112-124.
94. Humphrey H.E., Gardiner J.C., Pandya J.R., Sweeney A.M., Gasior D.M., McCaffrey R.J., et al. PCB congener profile in the serum of humans consuming Great Lakes fish. Environ Health Perspect 2000, 108:167-172.
95. Hung A.Y., Futai K., Sala C., Valtschanoff J.G., Ryu J., Woodworth M.A., et al. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci 2008, 28:1697-1708.
96. Hutsler J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 2010, 1309:83-94.
97. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997, 387:167-178.
98. Hwang H.M., Green P.G., Young T.M. Tidal salt marsh sediment in California, USA. Part 1: occurrence and sources of organic contaminants. Chemosphere 2006, 64:1383-1392.
99. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 2001, 98:161-167.
100. Jacobson S.M., Birkholz D.A., McNamara M.L., Bharate S.B., George K.M. Subacute developmental exposure of zebrafish to the organophosphate pesticide metabolite, chlorpyrifos-oxon, results in defects in Rohon-Beard sensory neuron development. Aquat Toxicol 2010, 100:101-111.
101. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
102. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A 2008, 105:1710-1715.
103. Jamshidi A., Hunter S., Hazrati S., Harrad S. Concentrations and chiral signatures of polychlorinated biphenyls in outdoor and indoor air and soil in a major U.K. conurbation. Environ Sci Technol 2007, 41:2153-2158.
104. Jaworski J., Spangler S., Seeburg D.P., Hoogenraad C.C., Sheng M. Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 2005, 25:11300-11312.
105. Jett D.A., Navoa R.V., Beckles R.A., McLemore G.L. Cognitive function and cholinergic neurochemistry in weanling rats exposed to chlorpyrifos. Toxicol Appl Pharmacol 2001, 174:89-98.
106. Johnstone A.F., Gross G.W., Weiss D.G., Schroeder O.H., Gramowski A., Shafer T.J. Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology 2010, 31:331-350.
107. Jolous-Jamshidi B., Cromwell H.C., McFarland A.M., Meserve L.A. Perinatal exposure to polychlorinated biphenyls alters social behaviors in rats. Toxicol Lett 2010, 199:136-143.
108. Judson M.C., Eagleson K.L., Levitt P. A new synaptic player leading to autism risk: Met receptor tyrosine kinase. J Neurodevelopmental Disord 2011, 3:282-292.
109. Kalia M. Brain development: anatomy, connectivity, adaptive plasticity, and toxicity. Metabolism 2008, 57(Suppl. 2):S2-S5.
110. Kelemenova S., Schmidtova E., Ficek A., Celec P., Kubranska A., Ostatnikova D. Polymorphisms of candidate genes in Slovak autistic patients. Psychiatr Genet 2010, 20:137-139.
111. Kenet T., Froemke R.C., Schreiner C.E., Pessah I.N., Merzenich M.M. Perinatal exposure to a noncoplanar polychlorinated biphenyl alters tonotopy, receptive fields, and plasticity in rat primary auditory cortex. Proc Natl Acad Sci U S A 2007, 104:7646-7651.
112. Keyes K.M., Susser E., Cheslack-Postava K., Fountain C., Liu K., Bearman P.S. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol 2012, 41:495-503.
113. Khosravani H., Altier C., Zamponi G.W., Colicos M.A. The Arg473Cys-neuroligin-1 mutation modulates NMDA mediated synaptic transmission and receptor distribution in hippocampal neurons. FEBS Lett 2005, 579:6587-6594.
114. Kiely T., Donaldson D., Grube A. Pesticides industry sales and usage: 2000 and 2001 market estimates 2004, US EPA, Washington DC.
115. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207.
116. Kim K.H., Bose D.D., Ghogha A., Riehl J., Zhang R., Barnhart C.D., et al. Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. Environ Health Perspect 2011, 119:519-526.
117. King M., Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol 2009, 38:1224-1234.
118. Kodavanti P.R.S. Neurotoxicity of persistent organic pollutants: possible mode(s) of action and further considerations. Dose Response 2005, 3:273-305.
119. Kofman O., Berger A., Massarwa A., Friedman A., Jaffar A.A. Motor inhibition and learning impairments in school-aged children following exposure to organophosphate pesticides in infancy. Pediatr Res 2006, 60:88-92.
120. 2+ fluctuations. J Neurobiol 1998, 37:110-130.
121. Korrick S.A., Sagiv S.K. Polychlorinated biphenyls, organochlorine pesticides and neurodevelopment. Curr Opin Pediatr 2008, 20:198-204.
122. Kossel A.H., Williams C.V., Schweizer M., Kater S.B. Afferent innervation influences the development of dendritic branches and spines via both activity-dependent and non-activity-dependent mechanisms. J Neurosci 1997, 17:6314-6324.
123. Kostyniak P.J., Hansen L.G., Widholm J.J., Fitzpatrick R.D., Olson J.R., Helferich J.L., et al. Formulation and characterization of an experimental PCB mixture designed to mimic human exposure from contaminated fish. Toxicol Sci 2005, 88:400-411.
124. Krakowiak P., Walker C.K., Bremer A.A., Baker A.S., Ozonoff S., Hansen R.L., et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012, 129:e1121-e1128.
125. Krebs M.O., Betancur C., Leroy S., Bourdel M.C., Gillberg C., Leboyer M. Absence of association between a polymorphic GGC repeat in the 5' untranslated region of the reelin gene and autism. Mol Psychiatry 2002, 7:801-804.
126. 2+ signaling. Curr Opin Neurobiol 2007, 17:112-119.
127. Krueger D.D., Bear M.F. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 2011, 62:411-429.
128. Kumar V., Zhang M.X., Swank M.W., Kunz J., Wu G.Y. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 2005, 25:11288-11299.
129. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
130. Laitinen P.J., Swan H., Piippo K., Viitasalo M., Toivonen L., Kontula K. Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia. Ann Med 2004, 36(Suppl. 1):81-86.
131. Landrigan P.J. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 2010, 22:219-225.
132. Landrigan P.J., Claudio L., Markowitz S.B., Berkowitz G.S., Brenner B.L., Romero H., et al. Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect 1999, 107(Suppl. 3):431-437.
133. Landrigan P.J., Lambertini L., Birnbaum L.S. A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Environ Health Perspect 2012, 120:a258-a260.
134. Lappalainen R., Lindholm D., Riikonen R. Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996, 11:296-300.
135. Larimore J.L., Chapleau C.A., Kudo S., Theibert A., Percy A.K., Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 2009, 34:199-211.
136. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004, 74:552-557.
137. Leblond C.S., Heinrich J., Delorme R., Proepper C., Betancur C., Huguet G., et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012, 8:e1002521.
138. Leehey M.A., Hagerman P.J. Fragile X-associated tremor/ataxia syndrome. Handb Clin Neurol 2012, 103:373-386.
139. Lein P., Johnson M., Guo X., Rueger D., Higgins D. Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Neuron 1995, 15:597-605.
140. Lein P., Silbergeld E., Locke P., Goldberg A.M. In vitro and other alternative approaches to developmental neurotoxicity testing (DNT). Environ Toxicol Pharmacol 2005, 19:735-744.
141. Levin E.D., Addy N., Nakajima A., Christopher N.C., Seidler F.J., Slotkin T.A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res 2001, 130:83-89.
142. Levin E.D., Addy N., Baruah A., Elias A., Christopher N.C., Seidler F.J., et al. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol 2002, 24:733-741.
143. Levitt P. Structural and functional maturation of the developing primate brain. J Pediatr 2003, 143:S35-S45.
144. Levitt P., Campbell D.B. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 2009, 119:747-754.
145. Lewine J.D., Andrews R., Chez M., Patil A.A., Devinsky O., Smith M., et al. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 1999, 104:405-418.
146. Li J., Nguyen L., Gleason C., Lotspeich L., Spiker D., Risch N., et al. Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet B Neuropsychiatr Genet 2004, 126B:51-57.
147. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
148. Liu J., Koscielska K.A., Cao Z., Hulsizer S., Grace N., Mitchell G., et al. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet 2012, 21:3795-3805.
149. Lizardi P.S., O'Rourke M.K., Morris R.J. The effects of organophosphate pesticide exposure on Hispanic children's cognitive and behavioral functioning. J Pediatr Psychol 2008, 33:91-101.
150. Lohmann C. Calcium signaling and the development of specific neuronal connections. Prog Brain Res 2009, 175:443-452.
151. Lohmann C., Wong R.O. Regulation of dendritic growth and plasticity by local and global calcium dynamics. Cell Calcium 2005, 37:403-409.
152. Lovasi G.S., Quinn J.W., Rauh V.A., Perera F.P., Andrews H.F., Garfinkel R., et al. Chlorpyrifos exposure and urban residential environment characteristics as determinants of early childhood neurodevelopment. Am J Public Health 2011, 101:63-70.
153. Lu A.T., Cantor R.M. Allowing for sex differences increases power in a GWAS of multiplex Autism families. Mol Psychiatry 2012, 17:215-222.
154. Lu C., Knutson D.E., Fisker-Andersen J., Fenske R.A. Biological monitoring survey of organophosphorus pesticide exposure among pre-school children in the Seattle metropolitan area. Environ Health Perspect 2001, 109:299-303.
155. Lugli G., Krueger J.M., Davis J.M., Persico A.M., Keller F., Smalheiser N.R. Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem 2003, 4:9.
156. Mariussen E., Fonnum F. Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit Rev Toxicol 2006, 36:253-289.
157. Marks A.R., Harley K., Bradman A., Kogut K., Barr D.B., Johnson C., et al. Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ Health Perspect 2010, 118:1768-1774.
158. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
159. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
160. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 2000, 10:963-973.
161. McAllister A.K., Katz L.C., Lo D.C. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 1996, 17:1057-1064.
162. McAllister A.K., Katz L.C., Lo D.C. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 1997, 18:767-778.
163. McCallister M.M., Maguire M., Ramesh A., Aimin Q., Liu S., Khoshbouei H., et al. Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology 2008, 29:846-854.
164. McCanlies E.C., Fekedulegn D., Mnatsakanova A., Burchfiel C.M., Sanderson W.T., Charles L.E., et al. Parental occupational exposures and Autism Spectrum Disorder. J Autism Dev Disord 2012, 42(11):2323-2334. (Nov).
165. Mendez MA, Horder J, Myers J, Coghlan S, Stokes P, Erritzoe D, et al. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology in press.
166. Metzger F. Molecular and cellular control of dendrite maturation during brain development. Curr Mol Pharmacol 2010, 3:1-11.
167. Missler M. Synaptic cell adhesion goes functional. Trends Neurosci 2003, 26:176-178.
168. Mitchell M.M., Woods R., Chi L.H., Schmidt R.J., Pessah I.N., Kostyniak P.J., et al. Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen 2012, 53:589-598.
169. Moody W.J., Bosma M.M. Ion channel development, spontaneous activity, and activity-dependent development in nerve and muscle cells. Physiol Rev 2005, 85:883-941.
170. Moreira E.G., Yu X., Robinson J.F., Griffith W., Hong S.W., Beyer R.P., et al. Toxicogenomic profiling in maternal and fetal rodent brains following gestational exposure to chlorpyrifos. Toxicol Appl Pharmacol 2010, 245:310-325.
171. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol Appl Pharmacol 1998, 149:107-119.
172. Moser V.C., Chanda S.M., Mortensen S.R., Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci 1998, 46:211-222.
173. Naldini L., Vigna E., Ferracini R., Longati P., Gandino L., Prat M., et al. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol Cell Biol 1991, 11:1793-1803.
174. Nazeer A., Ghaziuddin M. Autism spectrum disorders: clinical features and diagnosis. Pediatr Clin North Am 2012, 59:19-25. [ix].
175. Nguon K., Baxter M.G., Sajdel-Sulkowska E.M. Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates. Cerebellum 2005, 4:112-122.
176. Nguyen T., Sudhof T.C. Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J Biol Chem 1997, 272:26032-26039.
177. Okerlund N.D., Cheyette B.N. Synaptic Wnt signaling-a contributor to major psychiatric disorders?. J Neurodevelopmental Disord 2011, 3:162-174.
178. O'Roak B.J., State M.W. Autism genetics: strategies, challenges, and opportunities. Autism Res 2008, 1:4-17.
179. Page L.A., Daly E., Schmitz N., Simmons A., Toal F., Deeley Q., et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006, 163:2189-2192.
180. Pardo C.A., Eberhart C.G. The neurobiology of autism. Brain Pathol 2007, 17:434-447.
181. Park J.S., Linderholm L., Charles M.J., Athanasiadou M., Petrik J., Kocan A., et al. Polychlorinated biphenyls and their hydroxylated metabolites (OH-PCBS) in pregnant women from eastern Slovakia. Environ Health Perspect 2007, 115:20-27.
182. Pasca S.P., Nemes B., Vlase L., Gagyi C.E., Dronca E., Miu A.C., et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 2006, 78:2244-2248.
183. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 2011, [advance on-line pub].
184. Perera F.P., Rauh V., Whyatt R.M., Tsai W.Y., Tang D., Diaz D., et al. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3years of life among inner-city children. Environ Health Perspect 2006, 114:1287-1292.
185. Perera F.P., Tang D., Wang S., Vishnevetsky J., Zhang B., Diaz D., et al. Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6-7years. Environ Health Perspect 2012, 120:921-926.
186. Persico A.M., Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006, 29:349-358.
187. Persico A.M., Levitt P., Pimenta A.F. Polymorphic GGC repeat differentially regulates human reelin gene expression levels. J Neural Transm 2006, 113:1373-1382.
188. Pessah I.N., Lein P.J. Evidence for environmental susceptibility in autism: what we need to know about gene x environment interactions. Autism: current theories and evidence 2008, 409-428. Humana Press, Totowa, NJ. A. Zimmerman (Ed.).
189. 2+ channel complex type 1 (RyR1). Chem Res Toxicol 2006, 19:92-101.
190. Pessah I.N., Cherednichenko G., Lein P.J. Minding the calcium store: ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacol Ther 2010, 125:260-285.
191. Pomeroy-Black M.J., Jortner B.S., Ehrich M.F. Early effects of neuropathy-inducing organophosphates on in vivo concentrations of three neurotrophins. Neurotox Res 2007, 11:85-91.
192. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 1991, 68:51-61.
193. Powers B.E., Widholm J.J., Lasky R.E., Schantz S.L. Auditory deficits in rats exposed to an environmental PCB mixture during development. Toxicol Sci 2006, 89:415-422.
194. Quattrocchi C.C., Wannenes F., Persico A.M., Ciafre S.A., D'Arcangelo G., Farace M.G., et al. Reelin is a serine protease of the extracellular matrix. J Biol Chem 2002, 277:303-309.
195. Rauh V.A., Garfinkel R., Perera F.P., Andrews H.F., Hoepner L., Barr D.B., et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3years of life among inner-city children. Pediatrics 2006, 118:e1845-e1859.
196. Rauh V., Arunajadai S., Horton M., Perera F., Hoepner L., Barr D.B., et al. Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect 2011, 119:1196-1201.
197. Rauh V.A., Perera F.P., Horton M.K., Whyatt R.M., Bansal R., Hao X., et al. Brain anomalies in children exposed prenatally to a common organophosphate pesticide. Proc Natl Acad Sci U S A 2012, 109:7871-7876.
198. Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol 2003, 18:693-697.
199. Riikonen R., Vanhala R. Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome. Dev Med Child Neurol 1999, 41:148-152.
200. Robinette B.L., Harrill J.A., Mundy W.R., Shafer T.J. In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front Neuroeng 2011, 4:1.
201. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 1997, 11:417-422.
202. Roegge C.S., Wang V.C., Powers B.E., Klintsova A.Y., Villareal S., Greenough W.T., et al. Motor impairment in rats exposed to PCBs and methylmercury during early development. Toxicol Sci 2004, 77:315-324.
203. Rohlman D.S., Arcury T.A., Quandt S.A., Lasarev M., Rothlein J., Travers R., et al. Neurobehavioral performance in preschool children from agricultural and non-agricultural communities in Oregon and North Carolina. Neurotoxicology 2005, 26:589-598.
204. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003, 2:255-267.
205. Rudie J.D., Hernandez L.M., Brown J.A., Beck-Pancer D., Colich N.L., Gorrindo P., et al. Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron 2012, 75:904-915.
206. Sable H.J., Powers B.E., Wang V.C., Widholm J.J., Schantz S.L. Alterations in DRH and DRL performance in rats developmentally exposed to an environmental PCB mixture. Neurotoxicol Teratol 2006, 28:548-556.
207. 2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility. Cerebellum 2009, 8:312-322.
208. Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect 1993, 100:259-268.
209. Salinas P.C., Zou Y. Wnt signaling in neural circuit assembly. Annu Rev Neurosci 2008, 31:339-358.
210. Samso M., Feng W., Pessah I.N., Allen P.D. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol 2009, 7:e85.
211. Schantz S.L., Levin E.D., Bowman R.E., Heironimus M.P., Laughlin N.K. Effects of perinatal PCB exposure on discrimination-reversal learning in monkeys. Neurotoxicol Teratol 1989, 11:243-250.
212. Schantz S.L., Seo B.W., Wong P.W., Pessah I.N. Long-term effects of developmental exposure to 2,2',3,5',6-pentachlorobiphenyl (PCB 95) on locomotor activity, spatial learning and memory and brain ryanodine binding. Neurotoxicology 1997, 18:457-467.
213. Schantz S.L., Widholm J.J., Rice D.C. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 2003, 111:357-576.
214. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
215. Schmidt R.J., Hansen R.L., Hartiala J., Allayee H., Schmidt L.C., Tancredi D.J., et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 2011, 22:476-485.
216. Schmidt R.J., Tancredi D.J., Ozonoff S., Hansen R.L., Hartiala J., Allayee H., et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 2012, 96:80-89.
217. 2+/cAMP response element binding protein in cultured neurons. Toxicol Appl Pharmacol 2002, 182:176-185.
218. Scott-Van Zeeland A.A., Abrahams B.S., Alvarez-Retuerto A.I., Sonnenblick L.I., Rudie J.D., Ghahremani D., et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2010, 2:56ra80.
219. Serajee F.J., Zhong H., Mahbubul Huq A.H. Association of Reelin gene polymorphisms with autism. Genomics 2006, 87:75-83.
220. Shelton J.F., Hertz-Picciotto I., Pessah I.N. Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect 2012, 120:944-951.
221. Sheng L., Ding X., Ferguson M., McCallister M., Rhoades R., Maguire M., et al. Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci 2010, 118:625-634.
222. Silverman J.L., Turner S.M., Barkan C.L., Tolu S.S., Saxena R., Hung A.Y., et al. Sociability and motor functions in Shank1 mutant mice. Brain Res 2011, 1380:120-137.
223. Skaar D.A., Shao Y., Haines J.L., Stenger J.E., Jaworski J., Martin E.R., et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry 2005, 10:563-571.
224. Slotkin T.A., Cousins M.M., Tate C.A., Seidler F.J. Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res 2001, 902:229-243.
225. Slotkin T.A., Seidler F.J., Fumagalli F. Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro. Brain Res Bull 2008, 76:424-438.
226. Slotkin T.A., Levin E.D., Seidler F.J. Developmental neurotoxicity of parathion: progressive effects on serotonergic systems in adolescence and adulthood. Neurotoxicol Teratol 2009, 31:11-17.
227. Song J.Y., Ichtchenko K., Sudhof T.C., Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci U S A 1999, 96:1100-1105.
228. Spitzer N.C. Activity-dependent neurotransmitter respecification. Nat Rev Neurosci 2012, 13:94-106.
229. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
230. Stewart P., Darvill T., Lonky E., Reihman J., Pagano J., Bush B. Assessment of prenatal exposure to PCBs from maternal consumption of Great Lakes fish: an analysis of PCB pattern and concentration. Environ Res 1999, 80:S87-S96.
231. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
232. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004, 14:311-317.
233. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328.
234. Ta T.A., Pessah I.N. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95). Neurotoxicology 2007, 28:770-779.
235. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
236. Takei N., Inamura N., Kawamura M., Namba H., Hara K., Yonezawa K., et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci 2004, 24:9760-9769.
237. Tan G.C., Doke T.F., Ashburner J., Wood N.W., Frackowiak R.S. Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2. Neuroimage 2010, 53:1030-1042.
238. Tochigi M., Kato C., Ohashi J., Koishi S., Kawakubo Y., Yamamoto K., et al. No association between the ryanodine receptor 3 gene and autism in a Japanese population. Psychiatry Clin Neurosci 2008, 62:341-344.
239. Trusolino L., Bertotti A., Comoglio P.M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010, 11:834-848.
240. Tyndall S.J., Patel S.J., Walikonis R.S. Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-d-aspartate receptors and calcium/calmodulin-dependent kinases. J Neurosci Res 2007, 85:2343-2351.
241. Vanhala R., Korhonen L., Mikelsaar M., Lindholm D., Riikonen R. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome. J Child Neurol 1998, 13:429-433.
242. Varoqueaux F., Jamain S., Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 2004, 83:449-456.
243. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., et al. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
244. Veenstra-Vanderweele J., Christian S.L., Cook E.H. Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 2004, 5:379-405.
245. Volk H.E., Hertz-Picciotto I., Delwiche L., Lurmann F., McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 2011, 119:873-877.
246. Wayman G.A., Impey S., Marks D., Saneyoshi T., Grant W.F., Derkach V., et al. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 2006, 50:897-909.
247. Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Soderling T.R. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron 2008, 59:914-931.
248. Wayman G.A., Bose D.D., Yang D., Lesiak A., Bruun D., Impey S., et al. PCB-95 modulates the calcium-dependent signaling pathway responsible for activity-dependent dendritic growth. Environ Health Perspect 2012, 120:1003-1009.
249. Wayman G.A., Yang D., Bose D.D., Lesiak A., Ledoux V., Bruun D., et al. PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms. Environ Health Perspect 2012, 120:997-1002.
250. Wehrens X.H., Lehnart S.E., Marks A.R. Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005, 67:69-98.
251. Wheless J.W., Simos P.G., Butler I.J. Language dysfunction in epileptic conditions. Semin Pediatr Neurol 2002, 9:218-228.
252. Whyatt R.M., Barr D.B. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2001, 109:417-420.
253. Widholm J.J., Clarkson G.B., Strupp B.J., Crofton K.M., Seegal R.F., Schantz S.L. Spatial reversal learning in Aroclor 1254-exposed rats: sex-specific deficits in associative ability and inhibitory control. Toxicol Appl Pharmacol 2001, 174:188-198.
254. Winneke G. Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J Neurol Sci 2011, 308:9-15.
255. Wohr M., Roullet F.I., Hung A.Y., Sheng M., Crawley J.N. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One 2011, 6:e20631.
256. Wong P.W., Pessah I.N. Ortho-substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type microsomal calcium release channels. Mol Pharmacol 1996, 49:740-751.
257. Wong P.W., Brackney W.R., Pessah I.N. Ortho-substituted polychlorinated biphenyls alter microsomal calcium transport by direct interaction with ryanodine receptors of mammalian brain. J Biol Chem 1997, 272:15145-15153.
258. Wong P.W., Joy R.M., Albertson T.E., Schantz S.L., Pessah I.N. Ortho-substituted 2,2',3,5',6-pentachlorobiphenyl (PCB 95) alters rat hippocampal ryanodine receptors and neuroplasticity in vitro: evidence for altered hippocampal function. Neurotoxicology 1997, 18:443-456.
259. Wormley D.D., Ramesh A., Hood D.B. Environmental contaminant-mixture effects on CNS development, plasticity, and behavior. Toxicol Appl Pharmacol 2004, 197:49-65.
260. Yan J., Oliveira G., Coutinho A., Yang C., Feng J., Katz C., et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 2005, 10:329-332.
261. Yang D., Howard A., Bruun D., Ajua-Alemanj M., Pickart C., Lein P.J. Chlorpyrifos and chlorpyrifos-oxon inhibit axonal growth by interfering with the morphogenic activity of acetylcholinesterase. Toxicol Appl Pharmacol 2008, 228:32-41.
262. Yang D., Kim K.H., Phimister A., Bachstetter A.D., Ward T.R., Stackman R.W., et al. Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect 2009, 117:426-435.
263. Yang D., Lauridsen H., Buels K., Chi L.H., La Du J., Bruun D.A., et al. Chlorpyrifos-oxon disrupts zebrafish axonal growth and motor behavior. Toxicol Sci 2011, 121:146-159.
264. Yuen B., Boncompagni S., Feng W., Yang T., Lopez J.R., Matthaei K.I., et al. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. FASEB J 2012, 26:1311-1322.
265. Zaim M., Jambulingam P. Global insecticide use for vector-borne disease control 2007, World Health Organization, Geneva. 3rd ed. Diseases DoCoNT (Ed.).
266. Zerbo O., Iosif A.M., Walker C., Ozonoff S., Hansen R.L., Hertz-Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 2012, 43(1):25-33.
267. Zhang H., Liu X., Zhang C., Mundo E., Macciardi F., Grayson D.R., et al. Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 2002, 7:1012-1017.
268. Zhang H., Maximov A., Fu Y., Xu F., Tang T.S., Tkatch T., et al. Association of CaV1.3 L-type calcium channels with Shank. J Neurosci 2005, 25:1037-1049.
269. Zhou J., Blundell J., Ogawa S., Kwon C.H., Zhang W., Sinton C., et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009, 29:1773-1783.
270. Zikopoulos B., Barbas H. Changes in prefrontal axons may disrupt the network in autism. J Neurosci 2010, 30:14595-14609.
271. Zoghbi H.Y., Bear M.F. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 2012, 4.